Back to mobile site

Canaccord Genuity Maintains a 'Buy' on NuVasive (NUVA); Outpaces Market; Unique Asset at Cheap valuation

February 23, 2012 9:54 AM EST
Get Alerts NUVA Hot Sheet
Price: $39.75 --0%

Rating Summary:
    11 Buy, 21 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 6 | Down: 5 | New: 13
Join SI Premium – FREE
Canaccord Genuity maintains a 'Buy' on NuVasive (NASDAQ: NUVA) price target raised from $19 to $21.

Analyst, William J. Plovanic, said, "We maintain our rating following in-line Q4/11 results and mixed 2012 guidance. We believe NuVasive remains the gold standard in the lateral access market and will remain so due to a robust product pipeline and strong educational initiatives. Additionally, we believe geographic expansion and new product approvals and introductions represent upside to our expectations in 2012. Lastly, we believe NuVasive offers a favorable risk/reward profile at current valuation levels."

For an analyst ratings summary and ratings history on NuVasive click here. For more ratings news on NuVasive click here.

Shares of NuVasive closed at $15.46 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change